3DP is ushering in a new age of pharmaceutical manufacturing. And ZipDose technology, the world’s first and only FDA-validated, commercial-scale 3DP for pharma, is opening new possibilities in new therapeutic areas for drug manufacturers. With the fastest fast-melt capability available, significantly higher dosage loads and more taste masking options, the 3DP technology is clearly taking medicine “to its fullest potential.” It also enables a new world of powerful formulation solutions for NCE product candidates in Phase I or Phase II development and testing. And for manufacturers looking to extend patent exclusivity, ZipDose Technology’s new formulation capabilities also provide new pipeline potential and expanded patent opportunities to help address loss of exclusivity issues.